Genome-wide Estrogen Receptor-α activation is sustained, not cyclical.
cam.issuedOnline | 2018-11-20 | |
datacite.isderivedfrom.doi | 10.1101/398925 | |
dc.contributor.author | Holding, Andrew N | |
dc.contributor.author | Cullen, Amy E | |
dc.contributor.author | Markowetz, Florian | |
dc.contributor.orcid | Holding, Andrew N [0000-0002-8459-7048] | |
dc.contributor.orcid | Cullen, Amy E [0000-0002-5015-1355] | |
dc.contributor.orcid | Markowetz, Florian [0000-0002-2784-5308] | |
dc.date.accessioned | 2018-12-18T00:31:18Z | |
dc.date.available | 2018-12-18T00:31:18Z | |
dc.date.issued | 2018-11-20 | |
dc.description.abstract | Estrogen Receptor-alpha (ER) drives 75% of breast cancers. Stimulation of the ER by estra-2-diol forms a transcriptionally-active chromatin-bound complex. Previous studies reported that ER binding follows a cyclical pattern. However, most studies have been limited to individual ER target genes and without replicates. Thus, the robustness and generality of ER cycling are not well understood. We present a comprehensive genome-wide analysis of the ER after activation, based on 6 replicates at 10 time-points, using our method for precise quantification of binding, Parallel-Factor ChIP-seq. In contrast to previous studies, we identified a sustained increase in affinity, alongside a class of estra-2-diol independent binding sites. Our results are corroborated by quantitative re-analysis of multiple independent studies. Our new model reconciles the conflicting studies into the ER at the TFF1 promoter and provides a detailed understanding in the context of the ER's role as both the driver and therapeutic target of breast cancer. | |
dc.format.medium | Electronic | |
dc.identifier.doi | 10.17863/CAM.34362 | |
dc.identifier.eissn | 2050-084X | |
dc.identifier.issn | 2050-084X | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/287052 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | eLife Sciences Publications, Ltd | |
dc.publisher.url | http://dx.doi.org/10.7554/elife.40854 | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Estrogen | |
dc.subject | Estrogen Receptor | |
dc.subject | MCF7 | |
dc.subject | breast Cancer | |
dc.subject | chromosomes | |
dc.subject | computational biology | |
dc.subject | endocrine | |
dc.subject | gene expression | |
dc.subject | human | |
dc.subject | systems biology | |
dc.subject | Base Sequence | |
dc.subject | Binding Sites | |
dc.subject | Estradiol | |
dc.subject | Estrogen Receptor alpha | |
dc.subject | Female | |
dc.subject | Gene Expression Regulation, Neoplastic | |
dc.subject | Genome, Human | |
dc.subject | Genome-Wide Association Study | |
dc.subject | Humans | |
dc.subject | MCF-7 Cells | |
dc.subject | Neoplasm Proteins | |
dc.subject | Promoter Regions, Genetic | |
dc.subject | Protein Binding | |
dc.subject | Receptors, CXCR | |
dc.subject | Signal Transduction | |
dc.subject | Sorting Nexins | |
dc.subject | Trefoil Factor-1 | |
dc.title | Genome-wide Estrogen Receptor-α activation is sustained, not cyclical. | |
dc.type | Article | |
dcterms.dateAccepted | 2018-11-16 | |
prism.publicationDate | 2018 | |
prism.publicationName | Elife | |
prism.volume | 7 | |
pubs.funder-project-id | Breast Cancer Campaign (2012NovemberPR042) | |
pubs.funder-project-id | Cancer Research UK (C14303/A17197) | |
pubs.funder-project-id | Alan Turing Institute (Unknown) | |
pubs.funder-project-id | Cancer Research UK (19274) | |
pubs.funder-project-id | Cancer Research UK (24631) | |
rioxxterms.licenseref.startdate | 2018-11-20 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.type | Journal Article/Review | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.7554/eLife.40854 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- elife-40854-v2.pdf
- Size:
- 2.01 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version
- Licence
- https://creativecommons.org/licenses/by/4.0/
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- DepositLicenceAgreementv2.1.pdf
- Size:
- 150.9 KB
- Format:
- Adobe Portable Document Format